Information Technology & Internet Marketing Professional
Madison, Wisconsin Area
- Current
-
- Manager, Information Technology and Internet Marketing at Gentel Biosciences
- Past
-
- Manager, Global Internet Marketing at Promega Corporation
- Manager, Digital Communications at Promega Corporation
- Manager, Web Production at Promega Corporation
- Web Project Manager at Invitrogen Corporation
- Business Systems Analyst at Panvera Corporation
- Electronic Media Specialist/Systems Administrator at PanVera Corporation
- Scientist - Technical Services at Panvera Corporation
- Research Specialist & Medical Technologist at University of Wisconsin Hospital & Clinics
- Scientist - Research & Development at Third Wave Technologies
- Associate Research Specialist at University of Wisconsin
- Education
-
- University of Wisconsin-La Crosse
- Viterbo University
- Recommended
-
3 people have recommended Christopher - Connections
-
130
connections
- Industry
- Biotechnology
- Websites
Christopher Murvine’s Experience
-
Manager, Information Technology and Internet Marketing
Gentel Biosciences
(Biotechnology industry)
August 2008 — Present (2 months)
-
Manager, Global Internet Marketing
Promega Corporation
(Privately Held; 501-1000 employees; Biotechnology industry)
April 2007 — July 2008 (1 year 4 months)
Led the development and delivery of internet marketing programs while working with global teams to develop web strategies that increase revenue and build customer relationships. Drove end-to-end, integrated marketing programs that supported global product sampling campaigns, product launches and initiatives to drive revenue of long-tail product lines. Developed and managed customer/prospect communications including an opt-in, global e-mail marketing program to branch offices worldwide. Led search engine marketing, traffic acquisition and demand generation efforts including organic search engine optimization and cost-per-click advertising programs. Developed methodologies and implemented systems to monetize offline and online marketing tactics and calculate the return on investment of marketing spend. Provided strategic insight and drove innovation of Promega.com by leading projects related to information architecture, user experience, and social networking.
-
Manager, Digital Communications
Promega Corporation
(Privately Held; 501-1000 employees; Biotechnology industry)
October 2004 — April 2007 (2 years 7 months)
-
Manager, Web Production
Promega Corporation
(Privately Held; 501-1000 employees; Biotechnology industry)
January 2004 — October 2004 (10 months)
-
Web Project Manager
Invitrogen Corporation
(Public Company; 1001-5000 employees; IVGN; Biotechnology industry)
2003 — 2003 (less than a year)
Planned, developed, delivered, and managed corporate Internet, Extranet, and Intranet sites. Produced on-line media to enhance the company image and provide quality support materials for corporate and marketing functions. Worked with internal customers to determine business needs, develop cost/benefit analysis, define project scope, and align corporate strategies with current web technology. Documented and tracked web-related projects and maintained change request and control processes. Collaborated on web site events and on-line marketing initiatives, including the development of targeted e-mail marketing campaigns. Provided primary administration development and support for the corporate CRM system, including project management for CRM updates, implementation and deployment to remote staff.
-
Business Systems Analyst
Panvera Corporation
(Biotechnology industry)
2002 — 2003 (1 year)
-
Electronic Media Specialist/Systems Administrator
PanVera Corporation
(Privately Held; 51-200 employees; Biotechnology industry)
2000 — 2002 (2 years)
-
Scientist - Technical Services
Panvera Corporation
(Biotechnology industry)
1999 — 2000 (1 year)
Provided telephone and e-mail technical support for the PanVera and Takara product lines. Developed and delivered technical and non-technical training. Wrote and edited technical literature, participated in seminars and workshops, and attended scientific meetings.
-
Research Specialist & Medical Technologist
University of Wisconsin Hospital & Clinics
(Biotechnology industry)
September 1997 — November 1999 (2 years 3 months)
Provided serological and DNA-based analysis to support the University of Wisconsin Transplant Program, including matching of cadaver-donor organs. Performed short tandem repeat analysis of DNA to determine success of bone marrow transplants. Analyzed DNA sequences of organ transplant recipients to confirm MHC Class I and II typing. Synthesized custom primers to study MHC Class II typing of Rhesus Macaques.
-
Scientist - Research & Development
Third Wave Technologies
(Public Company; 201-500 employees; TWTI; Biotechnology industry)
December 1996 — September 1997 (10 months)
Developed and managed corporate DNA sequencing capability. Authenticated and confirmed DNA sequences of cancer-related p53 genes. Automated data collection of CFLP fragment data using fluorescent methods.
-
Associate Research Specialist
University of Wisconsin
(Educational Institution; 10,001 or more employees; Higher Education industry)
February 1996 — December 1996 (11 months)
Performed high-throughput, automated DNA sequencing of E. coli. Analyzed and assembled DNA sequences using bioinformatics systems. Mentored and managed student employees.
Additional Information
Christopher Murvine’s Websites:
Christopher Murvine’s Groups:
University of Wisconsin E-Business Consortium
Web Analytics Association
-
Internet Strategy Forum -
UW E-Business Consortium -
Email Marketing Roundtable -
eMarketing Association Network -
OBBeC B-to-B Biotechnology Network -
Biotech Marketing Group
Christopher Murvine’s Honors:
Google Certified AdWords Consultant
Contributing Author -- "Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis." J Clin Microbiol. 1997 December; 35(12): 3156–3162.
Contributing Author -- "Algorithmic Approach to High-Throughput Molecular Screening for Alpha Interferon-Resistant Genotypes in Hepatitis C Patients." J Clin Microbiol. 1998 July; 36(7): 1895–1901.
